Mitochondrial detachment of hexokinase 1 in mood and psychotic disorders: Implications for brain energy metabolism and neurotrophic signaling

Journal of Psychiatric Research

Volumn 46, Issue 1, 2012, Pages 95-104

  Regenold, W T ^a   Pratt, M ^a   Nekkalapu, S ^a   Shapiro, P S ^b   Kristian, T ^a   Fiskum, G ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Bipolar disorder; Glucose; Hexokinase; Major depression; Mitochondria; Schizophrenia

Indexed keywords

ADENOSINE TRIPHOSPHATE; HEXOKINASE 1; POLYOL;

ADULT; ARTICLE; BIPOLAR DISORDER; BRAIN DEVELOPMENT; BRAIN GROWTH; BRAIN METABOLISM; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; FEMALE; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; MALE; MITOCHONDRIAL MEMBRANE; MOOD DISORDER; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 81855161689     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.09.018     Document Type: Article

References (92)

1. Al-jamal J.A. Effect of different thyroid states on mitochondrial porin synthesis and hexokinase activity in developing rabbit brain. Journal of Biochemistry 2004, 135:253-258.
2. Ali F., Murthy A.S.N., Baquer N.Z. Hexokinase isoenzymes in diabetes. Journal of Biosciences 1980, 2:203-210.
3. Anders S., Birbaumer N., Sadowski B., Erb M., Mader I., Grodd W., et al. Parietal somatosensory association cortex mediates affective blindsight. Nature Neuroscience 2004, 7:339-340.
4. Artiges E., Salame P., Recasens C., Poline J.B., Attar-Levy D., De La Raillere A., et al. Working memory control in patients with schizophrenia: a PET study during a random number generation task. American Journal of Psychiatry 2000, 157:1517-1519.
5. Baddeley A. Working memory. Science 1992, 255:556-559.
6. BeltrandelRio H., Wilson J.E. Coordinated regulation of cerebral glycolytic and oxidative metabolism, mediated by mitochondrially bound hexokinase dependent on intramitochondrially generated ATP. Archives of Biochemistry and Biophysics 1992, 296:667-677.
7. Berenbaum H., Kerns J.G., Vernon L.L., Gomez J.J. Cognitive correlates of schizophrenia signs and symptoms: II. Emotional disturbances. Psychiatry Research 2008, 159:157-162.
8. Biver F., Goldman S., Delvenne V., Luxen A., De Maertelaer V., Hubain P., et al. Frontal and parietal metabolic disturbances in unipolar depression. Biological Psychiatry 1994, 36:381-388.
9. Carpenter W.T., Bartko J.J., Strauss J.S., Hawk A.B. Signs and symptoms as predictors of outcome: a report from the International Pilot Study of Schizophrenia. American Journal of Psychiatry 1978, 135:940-944.
10. Cataldo A.M., McPhie D.L., Lange N.T., Punzell S., Elmiligy S., Ye N.Z., et al. Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. American Journal of Pathology 2010, 1(77):575-585.
11. Christopher G., MacDonald J. The impact of clinical depression on working memory. Cognitive Neuropsychiatry 2005, 10:379-399.
12. Chuquet J., Quilichini P., Nimchinsky E.A., Buzsaki G. Predominant enhancement of glucose uptake in astrocytes versus neurons during activation of the somatosensory cortex. Journal of Neuroscience 2010, 30:15298-15303.
13. Clay H.B., Sillivan S., Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. International Journal of Developmental Neuroscience 2011, 29:311-324.
14. Cleghorn J.M., Garnett E.S., Nahmias C., Firnau G., Brown G.M., Kaplan R., et al. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia. Psychiatry Research 1989, 28:119-133.
15. Crane R.K., Sols A. The association of hexokinase with particulate fractions of brain and other tissue homogenates. Journal of Biological Chemistry 1953, 203:273-292.
16. da-Silva W.S., Gomez-Puyou A., de Gomez-Puyou M.T., Moreno-Sanchez R., De Felice F.G., de Meis L., et al. Mitochondrial bound hexokinase activity as a preventive antioxidant defense: steady-state ADP formation as a regulatory mechanism of membrane potential and reactive oxygen species generation in mitochondria. Journal of Biological Chemistry 2004, 279:39846-39855.
17. Dager S.R., Friedman S.D., Parow A., Demopulos C., Stoll A.L., Lyoo I.K., et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Archives of General Psychiatry 2004, 61:450-458.
18. Damasio A.R., Grabowski T.J., Bechara A., Damasio H., Ponto L.L., Parvizi J., et al. Subcortical and cortical brain activity during the feeling of self-generated emotions. Nature Neuroscience 2000, 3:1049-1056.
19. Danielson S.R., Carelli V., Tan G., Martinuzzi A., Schapira A.H., Savontaus M.L., et al. Isolation of transcriptomal changes attributable to LHON mutations and the cybridization process. Brain 2005, 128:1026-1037.
20. de Cerqueira Cesar M., Wilson J.E. Application of a double isotopic labeling method to a study of the interaction of mitochondrially bound rat brain hexokinase with intramitochondrial compartments of ATP generated by oxidative phosphorylation. Archives of Biochemistry and Biophysics 1995, 324:9-14.
21. El-Sayed M., Steen R.G., Poe M.D., Bethea T.C., Gerig G., Lieberman J., et al. Brain volumes in psychotic youth with schizophrenia and mood disorders. Journal of Psychiatry and Neuroscience 2010, 35:229-236.
22. Erecinska M., Silver I.A. ATP and brain function. Journal of Cerebral Blood Flow and Metabolism 1989, 9:2-19.
23. Fallin M.D., Lasseter V.K., Wolyniec P.S., McGrath J.A., Nestadt G., Valle D., et al. Genomewide linkage scan for bipolar-disorder susceptibility loci among Ashkenazi Jewish families. American Journal of Human Genetics 2004, 75:204-219.
24. Faraone S.V., Hwu H.G., Liu C.M., Chen W.J., Tsuang M.M., Liu S.K., et al. Genome scan of Han Chinese schizophrenia families from Taiwan: confirmation of linkage to 10q22.3. American Journal of Psychiatry 2006, 163:1760-1766.
25. Gabbay K.H., Merola L.O., Field R.A. Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes. Science 1966, 151:209-210.
26. Gonzalez-Gronow M., Cuchacovich M., Francos R., Cuchacovich S., Fernandez Mdel P., Blanco A., et al. Antibodies against the voltage-dependent anion channel (VDAC) and its protective ligand hexokinase-I in children with autism. Journal of Neuroimmunology 2010, 227:153-161.
27. Gottlob K., Majewski N., Kennedy S., Kandel E., Robey R.B., Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes & Development 2001, 15:1406-1418.
28. Hamakawa H., Murashita J., Yamada N., Inubushi T., Kato N., Kato T. Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry and Clinical Neurosciences 2004, 58:82-88.
29. Hattori N., Huang S.C., Wu H.M., Liao W., Glenn T.C., Vespa P.M., et al. Acute changes in regional cerebral (18)F-FDG kinetics in patients with traumatic brain injury. Journal of Nuclear Medicine 2004, 45:775-783.
30. Herzberg I., Jasinska A., Garcia J., Jawaheer D., Service S., Kremeyer B., et al. Convergent linkage evidence from two Latin-American population isolates supports the presence of a susceptibility locus for bipolar disorder in 5q31-34. Human Molecular Genetics 2006, 15:3146-3153.
31. Holmes E., Tsang T.M., Huang J.T., Leweke F.M., Koethe D., Gerth C.W., et al. Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS Medicine 2006, 3:e327.
32. Hong K.S., McInnes L.A., Service S.K., Song T., Lucas J., Silva S., et al. Genetic mapping using haplotype and model-free linkage analysis supports previous evidence for a locus predisposing to severe bipolar disorder at 5q31-33. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2004, 125B:83-86.
33. Huang T.J., Verkhratsky A., Fernyhough P. Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons. Molecular and Cellular Neuroscience 2005, 28:42-54.
34. Hutny J., Wilson J.E. Further studies on the role of phospholipids in determining the characteristics of mitochondrial binding sites for type I hexokinase. Acta Biochimica Polonica 2000, 47:1045-1060.
35. Iwamoto K., Bundo M., Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Human Molecular Genetics 2005, 14:241-253.
36. Jeffery J., Jornvall H. Enzyme relationships in a sorbitol pathway that bypasses glycolysis and pentose phosphates in glucose metabolism. Proceedings of the National Academy of Sciences, USA 1983, 80:901-905.
37. Jonides J., Schumacher E.H., Smith E.E., Koeppe R.A., Awh E., Reuter-Lorenz P.A., et al. The role of parietal cortex in verbal working memory. Journal of Neuroscience 1998, 18:5026-5034.
38. Kato T., Kapczinski F., Berk M. Mitochondrial dysfunction and oxidative stress. Bipolar disorder: clinical and neurobiological foundations 2010, 244-254. John Wiley & Sons, Ltd, Chichester. L.L.N. Yatham, M. Maj (Eds.).
39. Kato T., Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disorders 2000, 2:180-190.
40. Kato T., Kunugi H., Nanko S., Kato N. Association of bipolar disorder with the 5178 polymorphism in mitochondrial DNA. American Journal of Medical Genetics 2000, 96:182-186.
41. Kato T., Stine O.C., McMahon F.J., Crowe R.R. Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder. Biological Psychiatry 1997, 42:871-875.
42. Kishimoto H., Kuwahara H., Ohno S., Takazu O., Hama Y., Sato C., et al. Three subtypes of chronic schizophrenia identified using 11C-glucose positron emission tomography. Psychiatry Research 1987, 21:285-292.
43. Knull H.R., Taylor W.F., Wells W.W. Insulin effects on brain energy metabolism and the related hexokinase distribution. Journal of Biological Chemistry 1974, 249:6930-6935.
44. Konradi C., Eaton M., MacDonald M.L., Walsh J., Benes F.M., Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Archives of General Psychiatry 2004, 61:300-308.
45. Kung L., Roberts R.C. Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study. Synapse 1999, 31:67-75.
46. Land J.M., Booth R.F., Berger R., Clark J.B. Development of mitochondrial energy metabolism in rat brain. Biochemical Journal 1977, 164:339-348.
47. Li J.Z., Vawter M.P., Walsh D.M., Tomita H., Evans S.J., Choudary P.V., et al. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Human Molecular Genetics 2004, 13:609-616.
48. Lynch R.M., Fogarty K.E., Fay F.S. Modulation of hexokinase association with mitochondria analyzed with quantitative three-dimensional confocal microscopy. Journal of Cell Biology 1991, 112:385-395.
49. Mah L., Zarate C.A., Singh J., Duan Y.F., Luckenbaugh D.A., Manji H.K., et al. Regional cerebral glucose metabolic abnormalities in bipolar II depression. Biological Psychiatry 2007, 61:765-775.
50. Majewski N., Nogueira V., Bhaskar P., Coy P.E., Skeen J.E., Gottlob K., et al. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Molecular Cell 2004, 16:819-830.
51. Marcheco-Teruel B., Flint T.J., Wikman F.P., Torralbas M., Gonzalez L., Blanco L., et al. A genome-wide linkage search for bipolar disorder susceptibility loci in a large and complex pedigree from the eastern part of Cuba. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics 2006, 141B:833-843.
52. Maruff P., Wood S.J., Velakoulis D., Smith D.J., Soulsby B., Suckling J., et al. Reduced volume of parietal and frontal association areas in patients with schizophrenia characterized by passivity delusions. Psychological Medicine 2005, 35:783-789.
53. Miccoli L., Oudard S., Sureau F., Poirson F., Dutrillaux B., Poupon M.F. Intracellular pH governs the subcellular distribution of hexokinase in a glioma cell line. Biochemical Journal 1996, 313(Pt 3):957-962.
54. Molnar M.J., Valikovics A., Molnar S., Tron L., Dioszeghy P., Mechler F., et al. Cerebral blood flow and glucose metabolism in mitochondrial disorders. Neurology 2000, 55:544-548.
55. Ojeda N., Ortuno F., Arbizu J., Lopez P., Marti-Climent J.M., Penuelas I., et al. Functional neuroanatomy of sustained attention in schizophrenia: contribution of parietal cortices. Human Brain Mapping 2002, 17:116-130.
56. Olsen L., Hansen T., Jakobsen K.D., Djurovic S., Melle I., Agartz I., et al. The estrogen hypothesis of schizophrenia implicates glucose metabolism: association study in three independent samples. BMC Medical Genetics 2008, 9:39.
57. Ongur D., Lundy M., Greenhouse I., Shinn A.K., Menon V., Cohen B.M., et al. Default mode network abnormalities in bipolar disorder and schizophrenia. Psychiatry Research 2010, 183:59-68.
58. Oudard S., Poirson F., Miccoli L., Bourgeois Y., Vassault A., Poisson M., et al. Mitochondria-bound hexokinase as target for therapy of malignant gliomas. International Journal of Cancer 1995, 62:216-222.
59. Pellerin L., Magistretti P.J. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:10625-10629.
60. Prabakaran S., Swatton J.E., Ryan M.M., Huffaker S.J., Huang J.T., Griffin J.L., et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Molecular Psychiatry 2004, 9. 684-697, 643.
61. Quiroz J.A., Gray N.A., Kato T., Manji H.K. Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 2008, 33:2551-2565.
62. Regenold W.T., Hisley K.C., Obuchowski A., Lefkowitz D.M., Marano C., Hauser P. Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients. Journal of Affective Disorders 2005, 85:341-350.
63. Regenold W.T., Hisley K.C., Phatak P., Marano C.M., Obuchowski A., Lefkowitz D.M., et al. Relationship of cerebrospinal fluid glucose metabolites to MRI deep white matter hyperintensities and treatment resistance in bipolar disorder patients. Bipolar Disorders 2008, 10:753-764.
64. Regenold W.T., Kling M.A., Hauser P. Elevated sorbitol concentration in the cerebrospinal fluid of patients with mood disorders. Psychoneuroendocrinology 2000, 25:593-606.
65. Regenold W.T., Phatak P., Kling M.A., Hauser P. Post-mortem evidence from human brain tissue of disturbed glucose metabolism in mood and psychotic disorders. Molecular Psychiatry 2004, 9:731-733.
66. Regenold W.T., Phatak P., Marano C.M., Sassan A., Conley R.R., Kling M.A. Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis. Biological Psychiatry 2009, 65:489-494.
67. Reger M.A., Watson G.S., Green P.S., Wilkinson C.W., Baker L.D., Cholerton B., et al. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 2008, 70:440-448.
68. Robey R.B., Hay N. Mitochondrial hexokinases: guardians of the mitochondria. Cell Cycle 2005, 4:654-658.
69. Robey R.B., Hay N. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 2006, 25:4683-4696.
70. Rollins B., Martin M.V., Sequeira P.A., Moon E.A., Morgan L.Z., Watson S.J., et al. Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PLoS One 2009, 4:e4913.
71. Saraiva L.M., Seixas da Silva G.S., Galina A., da-Silva W.S., Klein W.L., Ferreira S.T., et al. Amyloid-beta triggers the release of neuronal hexokinase 1 from mitochondria. PLoS One 2010, 5:e15230.
72. Shao L., Martin M.V., Watson S.J., Schatzberg A., Akil H., Myers R.M., et al. Mitochondrial involvement in psychiatric disorders. Annals of Medicine 2008, 40:281-295.
73. Sims N.R., Anderson M.F. Isolation of mitochondria from rat brain using Percoll density gradient centrifugation. Nature Protocols 2008, 3:1228-1239.
74. Sklar P., Pato M.T., Kirby A., Petryshen T.L., Medeiros H., Carvalho C., et al. Genome-wide scan in Portuguese Island families identifies 5q31-5q35 as a susceptibility locus for schizophrenia and psychosis. Molecular Psychiatry 2004, 9:213-218.
75. Snyder C.D., Wilson J.E. Relative levels of hexokinase in isolated neuronal, astrocytic, and oligodendroglial fractions from rat brain. Journal of Neurochemistry 1983, 40:1178-1181.
76. Soong N.W., Hinton D.R., Cortopassi G., Arnheim N. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nature Genetics 1992, 2:318-323.
77. Soriano-Mas C., Hernandez-Ribas R., Pujol J., Urretavizcaya M., Deus J., Harrison B.J., et al. Cross-sectional and longitudinal assessment of structural brain alterations in melancholic depression. Biological Psychiatry 2011, 69:310-325.
78. Stone W.S., Faraone S.V., Su J., Tarbox S.I., Van Eerdewegh P., Tsuang M.T. Evidence for linkage between regulatory enzymes in glycolysis and schizophrenia in a multiplex sample. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2004, 127B:5-10.
79. Sun X., Wang J.F., Tseng M., Young L.T. Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. Journal of Psychiatry and Neuroscience 2006, 31:189-196.
80. Tangpong J., Cole M.P., Sultana R., Joshi G., Estus S., Vore M., et al. TNF-alpha-mediated central nervous system toxicity. Neurobiology of Disease 2006, 23:127-139.
81. Telenius H., Kremer B., Goldberg Y.P., Theilmann J., Andrew S.E., Zeisler J., et al. Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nature Genetics 1994, 6:409-414.
82. Tomlinson D.R., Gardiner N.J. Glucose neurotoxicity. Nature Reviews Neuroscience 2008, 9:36-45.
83. Torrey E.F., Webster M., Knable M., Johnston N., Yolken R.H. The Stanley foundation brain collection and neuropathology consortium. Schizophrenia Research 2000, 44:151-155.
84. Valvassori S.S., Rezin G.T., Ferreira C.L., Moretti M., Goncalves C.L., Cardoso M.R., et al. Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. Journal of Psychiatric Research 2010, 44:903-909.
85. Vawter M.P., Tomita H., Meng F., Bolstad B., Li J., Evans S., et al. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Molecular Psychiatry 2006, 11. 615, 663-679.
86. Venken T., Alaerts M., Souery D., Goossens D., Sluijs S., Navon R., et al. Chromosome 10q harbors a susceptibility locus for bipolar disorder in Ashkenazi Jewish families. Molecular Psychiatry 2008, 13:442-450.
87. Wang Z., Gardiner N.J., Fernyhough P. Blockade of hexokinase activity and binding to mitochondria inhibits neurite outgrowth in cultured adult rat sensory neurons. Neuroscience Letters 2008, 434:6-11.
88. Wilson J.E. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. Journal of Experimental Biology 2003, 206:2049-2057.
89. Wyss M.T., Jolivet R., Buck A., Magistretti P.J., Weber B. In vivo evidence for lactate as a neuronal energy source. Journal of Neuroscience 2011, 31:7477-7485.
90. Yates D.B., Dittmann S., Kapczinski F., Trentini C.M. Cognitive abilities and clinical variables in bipolar I depressed and euthymic patients and controls. Journal of Psychiatric Research 2010, 45:495-504.
91. Yuan P., Zhou R., Wang Y., Li X., Li J., Chen G., et al. Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia. Journal of Affective Disorders 2010, 124:164-169.
92. Zhao Z., Ksiezak-Reding H., Riggio S., Haroutunian V., Pasinetti G.M. Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction. Schizophrenia Research 2006, 84:1-14.